Pulmonary Fibrosis Foundation Community Registry

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Pulmonary fibrosis (PF) results from a diverse group of health conditions and affects the lives of patients (including those who are post lung transplant), caregivers and family members. The Pulmonary Fibrosis Foundation Community Registry will offer an online portal where participants can self-enroll and directly contribute information about their experience with PF to be compiled into a longitudinal data set for use by researchers.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

∙ In order to be eligible to participate in this study, an individual must meet all of the following criteria:

• Provision of signed and dated informed consent form online

• Male or female, aged 18 or older

• Affected by PF as a member of at least one of the following cohorts:

‣ An individual diagnosed with PF or ILD, including those who are post lung transplant, or

⁃ An individual who has cared (currently or in the past) for an individual with PF or ILD, and / or

⁃ A family member (defined as parent, full or half-sibling, or child) of an individual with PF or ILD.

• Has internet access and a valid email address.

Locations
United States
Illinois
Pulmonary Fibrosis Foundation
RECRUITING
Chicago
Contact Information
Primary
Jessica E Shore, PhD
registry@pulmonaryfibrosis.org
312-818-5731
Backup
Joseph Colbert, BA
pffr-dcc-pm@umich.edu
734-615-9813
Time Frame
Start Date: 2022-07-11
Estimated Completion Date: 2027-07-01
Participants
Target number of participants: 10000
Treatments
Patients
An individual diagnosed with PF or ILD, including those who are post lung transplant.
Family Members
A family member (defined as biological parent, full or half-sibling, or biological child) of an individual with PF or ILD.
Caregivers
An individual who has cared (currently or in the past) for an individual with PF or ILD.
Authors
Cathie Spino
Sponsors
Collaborators: University of Michigan
Leads: Pulmonary Fibrosis Foundation

This content was sourced from clinicaltrials.gov